We next performed a human cancer pathway finder PCR array, using HepG2‐FABP5 and HepG2 control cells to examine the hypothesis that FABP5 affects the expression of genes that contribute to HCC aggressiveness. The gene discussed is FABP5; the disease is hepatocellular carcinoma.